Search results for: 'space plan processing unit'

06 Jul 2023  |  Asia Pacific  |  Market Research

Asia-Pacific Real-time Payment Growth Opportunities

Disruptive Technologies that Enable Open Banking are Fueling the Growth of Real-time Payments

Infographics

×

This research service examines the real-time payment (RTP) market in the Asia-Pacific (APAC). It identifies key customer needs and market trends and provides a country-wise analysis of relevant developments. RTP or fast-payment systems involve payment transactions that are initiated and processed in near real time or within minutes. Unlike traditio...

19 Aug 2025  |  Global  |  Market Research

Building Construction Market, Global, 2025–2030

Building Construction is Experiencing Transformational Growth Due to Sustainability Practices and Digital Solutions Amidst Geopolitical Tensions

Infographics

×

The global building construction market is undergoing a significant transformation, with a shift in focus to sustainability and green building practices that prioritize eco-friendly approaches and energy efficiency throughout the value chain. Several new and advanced buildings now incorporate renewable energy and adopt sustainable strategies, such ...

The report is expected to support the strategic decision makers in the In Vitro Diagnostic (IVD) market that are either planning to expand or enter Thailand. The forecast of the major segments can help the diagnostic companies decide their next five years business plan. Segments in the market include molecular diagnostics, immunochemistry, and mic...

This strategic analysis is a part of Frost & Sullivan’s continued coverage of the global enterprise communications platforms and endpoints market as well as the broader, overall enterprise communications marketplace. In this Excel-based deliverable, Frost & Sullivan provides extensive market sizing and market share analysis of the on-premises enter...

Electric power systems providers are part of a broader ecosystem within the aerospace industry supply chain, where hundreds of companies co-exist with varying levels of complementarity and dependency. Commercial aviation has been seeing the highest levels of growth in recent years. Orders for new aircraft peaked in 2018, pushing the supply chain t...

15 Dec 2020  |  Global  |  Market Research

Demand for Autonomous Drones Is Accelerating Growth in Drone-in-a-Box Solutions

Technological Improvements Around Autonomous Flight and Artificial Intelligence are Enabling Advanced Capabilities

Infographics

×

Key Issues Addressed

The drone-in-a-box (DIB) market is nascent but will be rapidly transitioning to a growth market. While growth in this market is being driven by the demand for autonomous drones, regulatory restrictions that require pilots to maintain visual contact while operating commercial drones continue to pose the most significant roadblock. However, technolog...

The COVID-19 pandemic accelerated the move to digital channels, the cloud, and self-service customer care so financial companies could take advantage of new technologies to keep businesses running sans a staff yet maintain a satisfactory level of customer experience (CX). BFSI companies are focusing on improving digital experiences such as digital ...

Automotive manufacturing is a complex and ever-evolving industry shaped by technological advancements, economic conditions, and consumer preferences. As the demand for automobiles grew, automotive manufacturing has evolved from being highly reliant on manual labor to adopting new technologies and mass production techniques. The most important devel...

01 Mar 2024  |  North America  |  Market Research

Global Orphan Drug Growth Opportunities

Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions

Infographics

×

In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...